Press Release | August 23, 2023
Pyxis Oncology Successfully Completes Acquisition of Apexigen
Read More
News | August 17, 2023
Patent Awarded for Primary Template-Directed Amplification, Further Strengthening BioSkryb Genomics’ Core Technologies
Read More
Press Release | August 15, 2023
Precision BioSciences Completes Strategic Transaction with Imugene for Azer-Cel in Cancer
Read More
Press Release | August 3, 2023
Orchard Therapeutics Completes Submission of Biologics License Application for OTL-200 in MLD to U.S. FDA
Read More
